Table 2.

Clinical features, ocular history, prophylactic antibiotic usage, and outcomes for patients with endophthalmitis from whom MSSE isolates resistant to 8-methoxyfluoroquinolones were recovered^a

Patient	Age (yrs)	Gender	Yr isolate collected	Specimen	Eye	Prophylactic antibiotic(s)	Category	History	Initial VA	Final VAc
1	72	M	2005	Vitreous	OS	Moxifloxacin	Acute PO	Phacoemulsification 4 days priorb	HM	HM
2	NA	NA	2005	Vitreous	OS	Gatifloxacin	NA	NA	NA	NA
3	92	F	2006	Vitreous	OD	Gatifloxacin	After IV injection	Chronic macular edema; underwent multiple IV injections of avastin and macugen; last injection 1 day prior	LP	8/200
4	NA	NA	2006	AC	OS	NA	NA	NA	NA	NA
5	NA	NA	2007	Vitreous	OD	Moxifloxacin	NA	NA	NA	NA
6	56	M	2007	AC	OD	Moxifloxacin and vancomycin	Fungal keratitis	Underwent intracameral wash with voriconazole and PK for fungal keratitis	NA	NA
7	62	M	2007	Vitreous	OD	Moxifloxacin	Acute PO	Phacoemulsification 5 days prior	HM	NA
8	62	M	2008	Vitreous	OD	NA	Acute PO	Phacoemulsification 13 days prior	HM	20/60
9	62	F	2008	AC	OS	Gatifloxacin and ofloxacin	Delayed PO	Phacoemulsification 4 yrs prior and PK 18 mos prior; graft corneal suture lost 1 week prior	HM	NA
10	76	M	2008	Vitreous	OD	Moxifloxacin	Acute PO	Phacoemulsification 9 days prior	LP	20/200
11	88	F	2009	Vitreous	OD	Moxifloxacin	After IV injection	Patient with AMD; underwent multiple IV injections of lucentis and avastin; last injection 3 days prior	CF	20/40
12	78	F	2009	Vitreous	OD	Gatifloxacin	After IV injection	Patient with AMD; underwent multiple IV injections of avastin and macugen; last injection 4 days prior	HM	20/200d
13	82	F	2009	Vitreous	OD	Moxifloxacin	After IV injection	Underwent IV injection of lucentis 2 days prior	HM	20/40d
14	74	F	2009	Vitreous	OS	Gatifloxacin	Acute PO	Phacoemulsification 10 days prior	HM	20/80
15	68	F	2009	Vitreous	OS	Moxifloxacin	Acute PO	Phacoemulsification 4 days prior	HM	20/30d

^aAbbreviations: NA, not available; M, male; F, female; AC, anterior chamber; OS, left eye; OD, right eye; PO, postoperative; IV, intravitreal injection; VA, visual acuity; PK, penetrating keratoplasty; AMD, age-related macular degeneration; HM, hand motion; LP, light perception; CF, counting fingers.

^bThe time interval between the procedure and patient presentation at our eye institute.

^cVisual acuity at last follow-up.

^dVisual acuity with glasses.